What Wellcome Genome Campus does

The Wellcome Genome Campus is a non-profit research campus in Hinxton, Cambridgeshire, UK, established in 1994 and operated by Wellcome Genome Campus Limited (company number 15443042), a private company under the Wellcome Trust charitable foundation. It undertakes both wet and dry lab genome and biodata research, delivers bioinformatics services to the global scientific community, and provides training in genomics and biodata to scientists and clinicians. The campus is home to world-leading institutes including the Wellcome Sanger Institute and EMBL-EBI, the BioData Innovation Centre for tenant companies, and partner firms such as Congenica, Illumina and Open Targets, operating at the interface of academic research and industry.

Its core offerings cluster around five pillars: the BioData Innovation Centre (workspace and innovation hub), bioinformatics services delivered globally, genomics and biodata training programmes, public engagement through Yourgenome.org and school visits, and the Hinxton Hall Conference Centre for scientific events. The campus is currently expanding its physical footprint with The Sequence, a 147,000 sq ft, three-floor lab-enabled workspace building scheduled for Q4 2027, alongside a new Energy Farm sustainability initiative and a Science and Technology Advisory Group (STAG) of industry leaders formed in 2026.

The entity is not a commercial business and does not disclose pricing for services. Its operating model is funded through the Wellcome Trust and grant income, with revenue flowing through its parent foundation rather than via product sales. Distribution is via institutional collaborations, the BioData Innovation Centre tenancy model, and direct engagement with campus organisations, serving a global scientific community from a single UK site.

Name

Wellcome Genome Campus

Legal name

Wellcome Genome Campus Limited

Website

https://www.wellcomegenomecampus.org/

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Wellcome Genome Campus is a non-profit organization that specializes in biomedical research, genome, bioinformatics, and medical research.

Ownership category

akta.pro rank

Product category

Genomics Research and Bioinformatics Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Colleges, Universities, and Professional Schools (611310)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Public Research Universities with National Laboratories/Big Science Facilities (EDAHAAAJ), Scientific & Laboratory Reference (Chemistry, Biology, Physics; Methods & Protocols) (EDAGAGAG)

Keywords

• Genomics research
• Bioinformatics services
• Biodata analysis
• Life science training
• Genome sequencing

Headquarters

HQ city

Hinxton

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels2 records

Marketing channels3 records

Core offering

Wellcome Genome Campus undertakes genome and biodata research through both wet and dry lab science, delivers bioinformatics resources and services to the global scientific community, and provides vital training in genomics and biodata to scientists and clinicians. The campus operates as an integrated research-innovation hub hosting world-leading institutes, the BioData Innovation Centre, and partner companies, translating genomic science into tangible societal benefits.

Product overview

Wellcome Genome Campus is a unified campus offering rather than a modular platform. It provides a cluster of interconnected offerings: the BioData Innovation Centre as the primary hub for research activities, complemented by new lab-enabled workspace through The Sequence (147,000 sq ft, Q4 2027), bioinformatics services delivered globally, genomics and biodata training for scientists and clinicians, and ongoing campus expansion. The campus hosts world-leading institutes and organisations in genomics, biodata, health data, and data science.

Differentiator

Problem solved

Functional benefit

Products and services

• BioData Innovation Centre An innovation centre providing a home for genomics and biodata research development activities, supporting the growing community of world-leading institutes, organisations and experts at the campus. It serves life science and technology companies seeking a collaborative science ecosystem.
• Bioinformatics Services Bioinformatics resources and services delivered to the global scientific community, covering wet and dry lab science and basic research, translating science into tangible societal benefits.
• Genomics and Biodata Training Vital training in genomics and biodata delivered to scientists and clinicians, supporting education and professional development in the life sciences.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• BiolabscoreStrategic or Co-development Partner · 1 July 2026Landmark partnership to establish a new launchpad for life science and technology ventures at Wellcome Genome Campus, creating a collaborative ecosystem for emerging companies.
• VeoliacoreStrategic or Co-development PartnerVeolia was selected as preferred partner for a 5th generation heating and cooling network at Wellcome Genome Campus in Cambridgeshire, part of Veolia's Ecothermal Grid low-carbon heat network initiative.
• Science and Technology Advisory Group (STAG) MembersminorStrategic or Co-development PartnerIndustry leaders comprising the Science and Technology Advisory Group that guides the scientific and technological direction of the Wellcome Genome Campus.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Broad Institute: Joint Harvard/MIT biomedical and genomic research institute that, like Wellcome Genome Campus, sits at the interface of academic research, large-scale data science, and industry partnerships in genomics.
• Francis Crick Institute: Major UK biomedical research institute in London with a similar model of large-scale, multi-disciplinary life science research hosting partner organizations and translational programs.
• Babraham Research Campus: Cambridge-area life science campus combining research institutes (Babraham Institute) with bio-incubator space for startups, directly comparable to Wellcome Genome Campus's BIC and The Sequence offerings.
• Rosalind Franklin Institute: UK national institute for life science technology research, comparable as a publicly funded research hub focused on advanced technologies in biology and translational partnerships.
• Medical Research Council Laboratory of Molecular Biology (MRC-LMB): Cambridge-based world-leading molecular biology research institute that overlaps significantly with WGC's basic research mission and competes for talent in the same Cambridge life science cluster.

Emerging players

• New York Genome Center: A translational genomics research hub combining academic, industry, and clinical partners; comparable to WGC as a multi-institutional genomics center with industry-facing activities, though smaller and more US-centric.
• HudsonAlpha Institute for Biotechnology: Non-profit genomics and biodata research institute with co-located biotech companies on its campus, a comparable model of combining research with on-site industry incubation.

Broad incumbents

• Chan Zuckerberg Biohub: Large-scale biomedical research organization funded by philanthropic capital with a translational focus; comparable in mission and structure though broader in therapeutic scope than WGC.

Regional players

• Berlin Institute of Health: Translational biomedical research institute combining academic and clinical research in Berlin, comparable in mission to combine basic research with clinical translation, though operating in a different geography.
• BioInnovation Hub (Brussels): European life science innovation hub providing lab-enabled workspace and incubation for biotech ventures, comparable to WGC's BioData Innovation Centre and The Sequence offerings on the continent.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellcome Genome Campus